Poster Session II

Programme

• • Poster presentation
  • P002

  Immunization with the amino-terminus region of dense granule protein 6 (GRA6) of Toxoplasma gondii activates CD8+ cytotoxic T cells capable of removing tissue cysts of the parasite through antigen presentation by human HLA-A2.1

  • Dr. Rajesh Mani (Lexington, VT / US)

   Immunology of Acute & Chronic Infection
• • Poster presentation
  • P006

  Preliminary data of a time-controlled splitCas9 genome wide screen in Toxoplasma gondii

  • Ella Schadt (Planegg / DE)

   Genomics
• • Poster presentation
  • P008

  Stage-specific gene expression and signaling through chromatin: the paradigmatic interplay of Toxoplasma GCN5b and HDAC3

  • Dominique Cannella (Grenoble / FR)

   Genomics
• • Poster presentation
  • P010

  Anti-Apicomplexa drug discovery: Chemotherapeutic drug screening and target deconvolution in Toxoplasma gondii.

  • Dr. Laurence Braun (La Tronche / FR)
  • Alexandre Bougdour (La Tronche / FR)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P012

  Structural insight into the apicomplexan drug target cytochrome bc1

  • Dr. Andrew Maclean (Glasgow / GB)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P014

  Establishment of an E. coli model for studying the interaction and flexibility of apicoplast resident ferredoxin and bacterial flavodoxin redox systems towards IspH of the isoprenoid pathway

  • Ojo-Ajogu Akuh (Berlin / DE)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P016

  Biochemical mutagenesis signatures systematically identify functional palmitoylation post-translational modifications in Toxoplasma gondii

  • Dr. Matthew Child (London / GB)

   Host-Parasite Interaction & Signalling
• • Poster presentation
  • P018

  Exploring the Seroprevalence and Molecular Epidemiology of Toxoplasma gondii in Sheep Populations of Uruguay

  • Leandro Tana-Hernández (Montevideo / UY)

   Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
• • Poster presentation
  • P022

  Cross linking mass spectrometry: A new tool for studies on the Toxoplasma gondii protein interactome

  • Dr. Tadikimi Tomita (Bronx / US)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P024

  Identifying novel proteins that function in the regulation of arginine uptake in Toxoplasma gondii

  • Professor Giel G. van Dooren (Canberra / AU)

   Host-Parasite Interaction & Signalling
• • Poster presentation
  • P026

  Critical roles of an oxysterol-binding protein in lipid synthesis and trafficking in Toxoplasma gondii

  • Qin Biyun (Wuhan，China / CN)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P028

  Insights into the formation of the Toxoplasma plant-like vacuolar compartment

  • Professor Vernon B. Carruthers (Ann Arbor, MI / US)

   Cell Biology
• • Poster presentation
  • P030

  The role of NETosis and ROS production in human neutrophil-mediated host defense against Toxoplasma gondii infection

  • Dr. Tatiane Lima (Pomona / US)

   Innate Immunity and Immune Evasion
• • Poster presentation
  • P032

  First report of isolation of Toxoplasma gondii from Franciscana dolphin (Pontoporia blainvillei) in the South Coast of State of Santa Catarina, Brazil

  • Professor Anderson Barbosa de Moura (Lages / BR)

   Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
• • Poster presentation
  • P034

  DNA VACCINE ENCODING THE ROP18 GENE OF Toxoplasma gondii AGAINST OOCYSTS SHEDDING IN DOMESTIC CATS

  • Professor João Luís Garcia (Londrina / BR)

   Host-Parasite Interaction & Signalling
• • Poster presentation
  • P036

  Activity and efficacy of the bumped kinase inhibitor BKI-1708 in vitro and in non-pregnant and pregnant toxoplasmosis and neosporosis mouse models

  • Maria Ferreira de Sousa (Bern / CH)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P038

  TgGloL is an atypical glyoxalase domain-containing apicoplast protein that is important for the growth of Toxoplasma

  • Dr. Sébastien Besteiro (Montpellier / FR)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P040

  Exploiting Host Endoplasmic Reticulum: Toxoplasma gondii's Strategy for Amino Acid Acquisition and Brain Persistence

  • Leonardo Augusto (Omaha / US)

   Host-Parasite Interaction & Signalling
• • Poster presentation
  • P042

  Isolation and analysis of Toxoplasma gondii from a Japanese patient with congenital toxoplasmosis

  • Dr. Kisaburo Nagamune (Shinjuku-ku, Tokyo / JP)

   Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
• • Poster presentation
  • P044

  The Toxoplasma PQ-loop protein TgMPDU1 is essential for efficient parasite C-mannosylation

  • Dr. Federica Piro (Perugia / IT)

   Intracellular Replication & Survival
• • Poster presentation
  • P046

  In vitro evaluation of natural compounds extracts from Tabebuia against Toxoplasma gondii proliferation

  • Professor Jorge Enrique Gómez Marin (Armenia / CO)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P048

  Unraveling Morphological and Biomechanical Responses to Harsh Environmental Conditions in Coccidian Oocysts

  • Jana Elhusseiny (Marseille / FR)

   Cell Biology
• • Poster presentation
  • P050

  Toxoplasma resistance to mucin 2 and human cathelicidin LL-37

  • Dr. Pascale Guiton (Santa Clara / US)

   Host-Parasite Interaction & Signalling
• • Poster presentation
  • P052

  Susceptibility of eight Brazilian human isolates of Toxoplasma gondii to Sulfadiazine and Pyrimethamine

  • Dr. Erica Martins Duarte (Belo Horizonte / BR)

   Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
• • Poster presentation
  • P054

  Host cell traversal by Toxoplasma gondii sporozoites: evidence of an unprecedented force-producing mechanism

  • Professor Furio Spano (Rome / IT)

   Cell Biology
• • Poster presentation
  • P056

  Comparative proteomic analysis of Toxoplasma gondii Me49-derived strains adapted to in vitro treatments with thiosemicarbazones

  • Manuela Semeraro (Parma / IT)

   Metabolism, Biochemistry & Drug Development
• • Poster presentation
  • P058

  Fatal systemic toxoplasmosis with atypical steatitis in southern sea otters (Enhydra lutris nereis) associated with the COUG (TgCgCa1) strain

  • Dr. Devinn Sinnott (Davis / US)

   Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
• • Poster presentation
  • P060

  The Impact of Host Arginine Metabolism on Toxoplasma gondii Infection and Growth Dynamics.

  • Katie Barnes (Madison / US)

   Intracellular Replication & Survival